Effect of Treatment Regimens for Neisseria gonorrhoeae on Simultaneous Infection with Chlamydia trachomatis

Stamm, Walter E.; Guinan, Mary; Johnson, Carolyn; STARCHER, THOMAS; Holmes, King K.; McCormack, William M.

doi:10.1097/00006254-198407000-00019

Cited by 51 publications

(69 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[20][21][22] This is primarily because of methodological difficulties: long-term follow-up of untreated chlamydia infection would be unethical, but if diagnosed infections are treated the natural history has been altered; studies conducted in hospital or clinic populations may be affected by selection bias; 21 objective diagnosis of pelvic inflammatory disease is difficult; 23 and chlamydia cannot be unequivocally established as the cause of any sequelae, particularly after the acute infection has resolved. Early studies in clinical populations suggested that about 30% of untreated cervical chlamydial infections resulted in pelvic inflammatory disease within a few weeks, 17,24 and that 20-25% of women with pelvic inflammatory disease from any cause went on to have an ectopic pregnancy or become infertile. 25 It is thought that about 50% of chlamydia infections resolve spontaneously within a year, [26][27][28] and up to 90% of diagnosed pelvic inflammatory disease might be managed in primary care.…”

Section: Chlamydia and Its Clinical Consequencesmentioning

confidence: 99%

“…In the original model the occurrence of these sequelae was modelled statically because the most cited literature about the complications of chlamydial infection provides the data as a fixed probability. 24 Data were used from the Uppsala Women's Cohort Study, in which the cumulative incidences of pelvic inflammatory disease, ectopic pregnancy and infertility were estimated for a population of over 40,000 young women in Uppsala County, Sweden.…”

Section: Selecting a Modelling Approachmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection

Low

McCarthy²,

Macleod³

et al. 2007

Health Technol Assess

134

179

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) programme, now part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the costs, effectiveness and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as r...

show abstract

Section: Chlamydia and Its Clinical Consequencesmentioning

confidence: 99%

Section: Selecting a Modelling Approachmentioning

confidence: 99%

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection

Low

McCarthy²,

Macleod³

et al. 2007

Health Technol Assess

134

179

View full text Add to dashboard Cite

show abstract

“…All were conducted in sexually transmitted diseases clinics amongst women at high risk of PID with short follow up periods. In two studies, women were coinfected with gonorrhoea and chlamydia [156,157] and in one study they were partners of men with nongonococcal urethritis [158]. PID was ascertained in women treated with antibiotics that were active against gonorrhoea but not chlamydia, or received placebo.…”

Section: Risk Of Female Reproductive Tract Morbidity Resulting From Cmentioning

confidence: 99%

Opportunistic testing for urogenital infection with Chlamydia trachomatis in south-western Switzerland, 2012: a feasibility study

et al. 2015

View full text Add to dashboard Cite

The feasibility of opportunistic screening of urogenital infections with Chlamydia trachomatis was assessed in a cross-sectional study in 2012, in two cantons of south-western Switzerland: Vaud and Valais. Sexually active persons younger than?30 years, not tested for C. trachomatis in the last three months, were invited for free C. trachomatis testing by PCR in urine or self-applied vaginal swabs. Of 2,461 consenting participants, 1,899 (77%) were women and all but six (0.3%) submitted a sample. Forty-seven per cent of female and 25% of male participants were?younger than?20 years. Overall, 134 (5.5%) of 2,455 tested participants had a positive result and were followed up. Seven per cent of all candidates for screening were not invited, 10% of invited candidates were not eligible, 15% of the eligible candidates declined participation, 5% of tested participants testing positive were not treated, 29% of those treated were not retested after six months and 9% of those retested were positive for C. trachomatis. Opportunistic C. trachomatis testing proved technically feasible and acceptable, at least if free of charge. Men and peripheral rural regions were more difficult to reach. Efforts to increase testing and decrease dropout at all stages of the screening procedure are necessary.

show abstract

“…Tubal damage occurs as a result of pelvic inflammatory disease (PID). PID is estimated to occur subsequent to Chlamydial infection in 10 -40% of cases (Stamm, Guinan et al 1984), however, the diagnosis of PID depends on presentation of symptoms and a proportion of infection is known to be silent and undiagnosed because it is asymptomatic (Paarvonen and Eggert-Kruse 1999). Therefore, in any individual case it is not possible to determine whether PID has occurred.…”

Section: Chlamydia -A Threat To Fertilitymentioning

confidence: 99%

An Uncertain Future: Infertility and Chlamydial Infection

Piercy¹

2009

Emotions in Midwifery and Reproduction

View full text Add to dashboard Cite

IntroductionThis chapter considers the extent to which women regard an episode of genital chlamydial infection as a threat to their reproductive capabilities and the ways in which they manage the resultant anxieties. This discussion is founded upon the findings from a qualitative research study undertaken in central England which explored the experiences of women who were diagnosed with genital chlamydial infection and the ways in which they made sense of that experience.

show abstract

Effect of Treatment Regimens for Neisseria gonorrhoeae on Simultaneous Infection with Chlamydia trachomatis

Cited by 51 publications

References 0 publications

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection

Opportunistic testing for urogenital infection with Chlamydia trachomatis in south-western Switzerland, 2012: a feasibility study

An Uncertain Future: Infertility and Chlamydial Infection

Contact Info

Product

Resources

About